Literature DB >> 17874192

Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data.

Raffaella Uccelli1, Alessandra Binazzi, Pierluigi Altavista, Stefano Belli, Pietro Comba, Marina Mastrantonio, Nicola Vanacore.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a rare and devastating neurological disorder of the adult age with a prognosis of about 2-3 years from the onset of the disease. No clear cause has been identified but it seems to be a multifactorial disease with genetic and environmental components involved. Increments of mortality rates were observed since 1980 both in Italy and in many other countries. The objective of the present study is to describe the distribution of ALS mortality in Italy in the period 1980-2001 detecting single municipalities or clusters with high mortality levels for motor neuron disease (MND). ALS represents the main part (85%) of the MND group which is globally identified by the IX ICD (International Classification of Diseases and Causes of Death) 335.2 code. Death numbers and standardized mortality ratios (SMR) for MND were calculated for all Italian municipalities through the ENEA mortality database system (data source: National Institute of Statistics-ISTAT), using national mortality rates as reference. Subsequently, in order to detect municipal clusters, spatial analysis was performed. Out of the 8,099 Italian municipalities, 132 where characterized by SMR values higher than expected. Moreover 16 clusters with significant high relative risk values (RR) were identified, 12 out of them including only a single municipality. Only 22 of the municipalities with high SMR were included in the clusters. In conclusion, the two different epidemiological methodologies demonstrated to be widely complementary in detecting the geographical distribution of the disease in terms of risk for populations. A first selection of the priority areas where analytical studies should be carried on, in order to identify risk factors associated to ALS, is tentatively suggested.

Entities:  

Mesh:

Year:  2007        PMID: 17874192     DOI: 10.1007/s10654-007-9173-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  60 in total

Review 1.  Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population-based case-control study.

Authors:  D C Cruz; L M Nelson; V McGuire; W T Longstreth
Journal:  Neuroepidemiology       Date:  1999       Impact factor: 3.282

2.  Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death.

Authors:  C E Sabel; P J Boyle; M Löytönen; A C Gatrell; M Jokelainen; R Flowerdew; P Maasilta
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

3.  Pesticide toxicity and motor neuron disease.

Authors:  G B Steventon; R H Waring; A C Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-07       Impact factor: 10.154

4.  Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease?

Authors:  Stefano Belli; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  The epidemiology of motor neuron disease in Scotland.

Authors:  S M Holloway; A E Emery
Journal:  Muscle Nerve       Date:  1982-02       Impact factor: 3.217

6.  Abnormal distribution of lead in amyotrophic lateral sclerosis--reestimation of lead in the cerebrospinal fluid.

Authors:  S Conradi; L O Ronnevi; G Nise; O Vesterberg
Journal:  J Neurol Sci       Date:  1980-12       Impact factor: 3.181

7.  Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy.

Authors:  A Chiò; A Cucatto; A Calvo; A A Terreni; C Magnani; D Schiffer
Journal:  J Neurol       Date:  1999-03       Impact factor: 4.849

8.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.

Authors:  S Hadano; C K Hand; H Osuga; Y Yanagisawa; A Otomo; R S Devon; N Miyamoto; J Showguchi-Miyata; Y Okada; R Singaraja; D A Figlewicz; T Kwiatkowski; B A Hosler; T Sagie; J Skaug; J Nasir; R H Brown; S W Scherer; G A Rouleau; M R Hayden; J E Ikeda
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

9.  CuZn-superoxide dismutase in D90A heterozygotes from recessive and dominant ALS pedigrees.

Authors:  P Andreas Jonsson; Asa Bäckstrand; Peter M Andersen; Johan Jacobsson; Matthew Parton; Chris Shaw; Robert Swingler; Pamela J Shaw; Wim Robberecht; Albert C Ludolph; Teepu Siddique; Veronica I Skvortsova; Stefan L Marklund
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

10.  Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy.

Authors:  G Rosati; L Pinna; E Granieri; I Aiello; R Tola; V Agnetti; A Pirisi; P de Bastiani
Journal:  Acta Neurol Scand       Date:  1977-03       Impact factor: 3.209

View more
  15 in total

Review 1.  Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Peter W French; Russell Ludowyke; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

2.  Biomedical ontologies in action: role in knowledge management, data integration and decision support.

Authors:  O Bodenreider
Journal:  Yearb Med Inform       Date:  2008

Review 3.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 4.  Potential Environmental Factors in Amyotrophic Lateral Sclerosis.

Authors:  Björn Oskarsson; D Kevin Horton; Hiroshi Mitsumoto
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

5.  The accuracy of discharge diagnosis coding for Amyotrophic Lateral Sclerosis in a large teaching hospital.

Authors:  Federica Edith Pisa; Lorenzo Verriello; Laura Deroma; Daniela Drigo; Paolo Bergonzi; Gian Luigi Gigli; Fabio Barbone
Journal:  Eur J Epidemiol       Date:  2009-08-06       Impact factor: 8.082

6.  Exploring motor and visual imagery in Amyotrophic Lateral Sclerosis.

Authors:  F Fiori; A Sedda; E R Ferrè; A Toraldo; M Querzola; F Pasotti; D Ovadia; C Piroddi; R Dell'aquila; C Lunetta; M Corbo; G Bottini
Journal:  Exp Brain Res       Date:  2013-03-17       Impact factor: 1.972

7.  Spatial analyses of ALS incidence in Denmark over three decades.

Authors:  Verónica M Vieira; Johnni Hansen; Ole Gredal; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-01-31       Impact factor: 4.092

8.  The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study.

Authors:  Marco Vinceti; Francesca Bonvicini; Kenneth J Rothman; Luciano Vescovi; Feiyue Wang
Journal:  Environ Health       Date:  2010-12-06       Impact factor: 5.984

Review 9.  The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.

Authors:  Sandra Anne Banack; Tracie A Caller; Elijah W Stommel
Journal:  Toxins (Basel)       Date:  2010-12-20       Impact factor: 4.546

10.  The Rotterdam Study: 2010 objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.